This Monday, July 25, from 7-8 pm ET, join an AANP webinar to learn the latest on the FDA’s treatment of compounded medications – and all the ways AANP is fighting for NDs and their patients on this important issue.
Compounded medications remain in the cross-hairs of the FDA and its Pharmacy Compounding Advisory Committee. AANP scored a victory on June 23 with a successful defense of DMPS. However, many compounds - including MSM, curcumin, boswellia, germanium, and acetyl-l-carnitine - are being put on the FDA's "do not compound" list and the fate of many more remains undecided.
In this webinar, you'll hear from the leader of AANP's Work Group – Michael Cronin, ND – and from Paul Anderson, NMD, who defended the value of DMPS and other compounds at the recent FDA meeting. Attorney Alan Dumoff will also explain what it takes to challenge the FDA's process and actions.
Learn not just what's transpired but how AANP is stepping up its campaign to preserve office use and to maintain access to safely compounded medications. Most important, learn how you can pitch in! Register now
Director of Government and Public Affairs
American Association of Naturopathic Physicians
818 18th Street NW, Suite 250
Washington, DC 20006